Yuyu Pharma, Inc.
000220 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000220004
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 제천시 바이오밸리1로 94, 제천시
- Website:
- https://www.yuyu.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.4 KB | ||
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 123.1 KB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 52.2 KB | ||
| 2025-07-15 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 67.0 KB | ||
| 2025-07-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 117.4 KB | ||
| 2025-05-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 67.6 KB | ||
| 2025-05-22 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 12.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-04-22 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 14.7 KB | ||
| 2025-04-15 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 24.0 KB | ||
| 2025-04-15 00:00 |
Capital/Financing Update
기타경영사항(자율공시)
|
Korean | 5.9 KB | ||
| 2025-04-11 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
|
Korean | 32.8 KB | ||
| 2025-03-27 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 14.0 KB | ||
| 2025-03-27 00:00 |
AGM Information
정기주주총회결과
|
Korean | 32.9 KB |
Automate Your Workflow. Get a real-time feed of all Yuyu Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Yuyu Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Yuyu Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
United States of America
ALNY
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG
United States of America
ACOG
Manufactures critical reagents for biopharma, scaling from research to GMP manufacturing.
United States of America
TKNO
United States of America
TKNO
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
United States of America
ATHE
Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.
United States of America
ALT
United States of America
ALT
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
United States of America
ANRO
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
United States of America
ALMS
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
Luxembourg
ALVO
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
United States of America
ALXO
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
United States of America
ALZN